老年乳腺癌幸存者的心理健康结局:CLIMB 研究的五年随访
本研究纳入 299 例 ≥70 岁早期乳腺癌女性,平均年龄 75.8(标准差 5.2)岁,在诊断后 3、9、15、27 和 60 个月随访抑郁症状、孤独感和淡漠。3 个月时 10% 有显著抑郁症状,孤独感和淡漠分别为 31% 和 41%;全队列各项评分随时间无临床相关变化,接受辅助全身治疗者与未接受者心理健康结局相似,但衰弱患者症状更多且更易随时间出现抑郁症状。
要点
- 3 个月随访时 10% 患者有显著抑郁症状,31% 有孤独感,41% 有淡漠。
- 全队列抑郁、孤独感和淡漠评分随访 5 年无临床相关变化。
- 衰弱患者症状更多(p < 0.001)且更易随时间出现抑郁症状(p = 0.002)。
核心结论
- 老年乳腺癌女性中抑郁、孤独感和淡漠常见,且随时间无变化。
- 接受辅助全身治疗者与未接受者心理健康结局相似。
- 衰弱患者出现这些症状的风险更高。
研究设计与样本
- CLIMB 研究为纵向随访研究,纳入 ≥70 岁早期乳腺癌女性 299 例,平均年龄 75.8(标准差 5.2)岁。
- 采用多变量线性混合模型评估诊断后 3、9、15、27 和 60 个月随访时抑郁症状、孤独感和淡漠的纵向变化。
主要发现
- 3 个月随访时,10% 患者有显著抑郁症状,31% 有孤独感,41% 有淡漠。
- 全队列抑郁、孤独感和淡漠评分随时间无临床相关变化。
- 接受辅助全身治疗(内分泌治疗和/或化疗和/或靶向治疗(曲妥珠单抗))者与未接受者心理健康结局相似。
- 衰弱患者症状更多(p < 0.001),且比非衰弱患者更易随时间出现抑郁症状(p = 0.002)。
关键数值与推荐
- 抑郁症状采用 15 项老年抑郁量表评估。
- 孤独感采用 De Jong Gierveld 孤独量表评估。
- 淡漠采用 Starkstein 淡漠量表评估。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is a lack of information on mental health outcomes for the increasing older population. Therefore, the aim of the current study is to assess depressive symptoms, loneliness, and apathy in older patients with breast cancer within the first 5 years after diagnosis. METHODS: Women aged ≥70 years with early-stage breast cancer were included. Multivariate linear mixed models were used to assess longitudinal changes in symptoms of depression (according to the 15-item Geriatric Depression Scale), loneliness (according to the De Jong Gierveld Loneliness Scale) and apathy (according to the Starkstein Apathy Scale) over time at 3, 9, 15, 27 and 60 months follow-up. RESULTS: In total, 299 patients were included (mean [standard deviation (SD)] age: 75.8 [5.2] years). At 3 months follow-up, shortly after the acute treatment, 10% of patients had significant depressive symptoms, while loneliness and apathy were present in 31% and 41% of all patients, respectively. Depression, loneliness and apathy scores showed no clinically relevant changes over time in the whole cohort. Patients who received adjuvant systemic therapies (i.e. endocrine therapy and/or chemotherapy and/or targeted therapy (trastuzumab)) had similar mental health outcomes as those who did not. However, frail patients had more symptoms (p < 0.001) and were more prone to develop depressive symptoms over time than non-frail patients (p = 0.002). DISCUSSION: Depression, loneliness and apathy were frequently observed in older women with breast cancer and did not change over time. Patients who received adjuvant systemic therapies had similar mental health outcomes as those who did not. However, frail patients were at higher risk to experience these symptoms.
引用
- Lemij AA, de Glas NA, Derks MGM, et al. Mental health outcomes in older breast cancer survivors: Five-year follow-up from the CLIMB study. Eur J Cancer. 2023. PMID: 37130464. doi:10.1016/j.ejca.2023.04.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。